Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D050260:Carbohydrate Metabolism; D002747:Chlorpropamide / Q000008:administration & dosage*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D006029:Glycosuria / Q000188:drug therapy; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007330:Insulin Antibodies / Q000096:biosynthesis; D007333:Insulin Resistance; D007336:Insulin, Isophane / Q000627:therapeutic use; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009765:Obesity; D010629:Phenformin / Q000008:administration & dosage*; D014044:Tolbutamide / Q000627:therapeutic use
D001786:Blood Glucose; D007328:Insulin; D007330:Insulin Antibodies; D049528:Insulin, Long-Acting; D007336:Insulin, Isophane; D014044:Tolbutamide; D010629:Phenformin; D002747:Chlorpropamide